6Jin M, lnous S, Umemura T, et al. Cyclin D1, p16 and retinoblastom:a gene product expression as a proedictor for prognosis in non-small cell lung cancer at stages Ⅰ and Ⅱ [J]. Lung Cancer,2001,34(2) :207-218. 被引量：1
7Kersting M, Friedl C, Krans A, et al. Differential frequencies of p16 (INK4a) promoter hypemethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smakers [ J ]. J Clin Oncol, 2000,18(8) :3221-3229. 被引量：1
8Zochbauer-Muller S, Fong KM, Vimani AK, et al. Aberrant promotermethylation of multipie genes in non-small cell lung cancers[J]. Cancer Res,2001,61 ( 1 ) :249-255. 被引量：1
4[1]McKay JA,Douglas JJ,Ross VG,et al.Analysis of key cell-cycle checkpoint proteins in colorectal tumours.J Pathol,2002,196:386-393. 被引量：1
5[2]Nagai MA.Genetic alterations in head and neck squamous cell carcinomas. Braz J Med Biol Res,1999,32:897-904. 被引量：1
6[3]He XS,Su Q,Chen ZC,et al.Expression,deletion and mutation of p16 gene in human gastric cancer.World J Gastroenterol,2001,7:515-521. 被引量：1
7[4]Umekita Y,Ohi Y,Sagara Y,et al.Over expression of cyclinD1 predicts for poor prognosis in estrogen receptor-negative breast cancer patients.Int J Cancer,2002,98:415-418. 被引量：1
8[5]Kang Y,Ozbun LL,Angdisen J,et al.Altered expression of G1/S regulatory genes occurs early and frequently in lung carcinogenesis.Carcinogenesis,2002,23:1217-1227. 被引量：1
